Please assess the completion status of the following clinical trial:

Trial Title: Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The female partner must be aged 18-43 years and going through a fresh IVF cycle~Exclusion Criteria:~* Couples will be excluded from enrollment if they have any contraindication to antibiotic treatment, are not intending to undergo embryo transfer (fertility preservation patients and oocyte donors), require use of extended antibiotic coverage at time of egg retrieval, are already on antibiotics for any reason (e.g., upper respiratory infection), have a recent history of pelvic infection, or are planning on limited insemination (inseminating a limited number of the eggs retrieved) or are using donor sperm.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 43 Years
- Healthy Volunteers: t

Study Arms:
- Prophylactic antibiotics (Type: NO_INTERVENTION): Current standard of care in our practice for a fresh in vitro fertilization cycle is to administer one dose of 1 gram oral azithromycin on day one of the IVF cycle start to both the male and female partner. In cases of same-sex couples, only the female undergoing the embryo transfer receives prophylaxis. This will serve as our control arm entitled: prophylactic antibiotics.
- No antibiotic prophylaxis. (Type: EXPERIMENTAL): Couples randomized to the no-antibiotic treatment group will not be prescribed oral antibiotic prophylaxis.

Based on this trial design, predict the completion outcome and termination type (if applicable).